Contact
Please use this form to send email to PR contact of this press release:
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema
TO:
Please use this form to send email to PR contact of this press release:
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema
TO: